- Home
- MDV vs SRZN Comparison
MDV vs SRZN Comparison
Compare MDV & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDV | SRZN |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.4M | 164.3M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | MDV | SRZN |
|---|---|---|
| Price | $15.04 | $22.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 35.2K | ★ 149.0K |
| Earning Date | 03-03-2026 | 11-07-2025 |
| Dividend Yield | ★ 7.89% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $47,479,000.00 | $3,604,000.00 |
| Revenue This Year | $0.13 | N/A |
| Revenue Next Year | $0.71 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.62 | $5.90 |
| 52 Week High | $17.15 | $24.94 |
Technical Indicators
Market Signals| Indicator | MDV | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 56.05 | 60.39 |
| Support Level | $14.93 | $19.51 |
| Resistance Level | $15.51 | $23.37 |
| Average True Range (ATR) | 0.34 | 2.05 |
| MACD | 0.04 | 0.27 |
| Stochastic Oscillator | 65.22 | 84.63 |
Price Performance
Historical ComparisonAbout MDV Modiv Industrial Inc. Class C
Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).